As a verb inhibit

is to hinder; to restrain.

As a noun miglustat is

a drug used primarily to treat certain kinds of gaucher's disease by inhibiting glucosylceramide synthase, an essential enzyme for the synthesis of most glycosphingolipids.

As nouns the difference between glucosylceramide and miglustat

is that glucosylceramide is (biochemistry) glucocerebroside while miglustat is a drug used primarily to treat certain kinds of gaucher's disease by inhibiting glucosylceramide synthase, an essential enzyme for the synthesis of most glycosphingolipids.

As nouns the difference between synthase and miglustat

is that synthase is (enzyme) any enzyme that catalyzes the synthesis of a biological compound but, unlike synthetases, does not make use of atp as a source of energy while miglustat is a drug used primarily to treat certain kinds of gaucher's disease by inhibiting glucosylceramide synthase, an essential enzyme for the synthesis of most glycosphingolipids.

As a verb enzyme

is .

As a noun miglustat is

a drug used primarily to treat certain kinds of gaucher's disease by inhibiting glucosylceramide synthase, an essential enzyme for the synthesis of most glycosphingolipids.

Glucocerebrosidase is a synonym of glucosylceramidase.

As nouns the difference between glucosylceramidase and glucocerebrosidase

is that glucosylceramidase is glucocerebrosidase while glucocerebrosidase is an enzyme that is needed to cleave, by hydrolysis, the beta-glucosidic linkage of glucocerebroside, an intermediate in glycolipid metabolism, and mutations in which cause Gaucher's disease.

As nouns the difference between medication and imiglucerase

is that medication is medication while imiglucerase is a medication used in the treatment of gaucher's disease, a recombinant dna-produced analogue of human β-glucocerebrosidase.

As nouns the difference between analogue and imiglucerase

is that analogue is (british|canadian) while imiglucerase is a medication used in the treatment of gaucher's disease, a recombinant dna-produced analogue of human β-glucocerebrosidase.

As an adjective analogue

is (british|canadian).

As an adjective human

is (label) classical (of or pertaining to the classical - latin, greek - languages, literature, history and philosophy).

As a noun imiglucerase is

a medication used in the treatment of gaucher's disease, a recombinant dna-produced analogue of human β-glucocerebrosidase.

As nouns the difference between glucocerebrosidase and imiglucerase

is that glucocerebrosidase is (biochemistry) an enzyme that is needed to cleave, by hydrolysis, the beta-glucosidic linkage of glucocerebroside, an intermediate in glycolipid metabolism, and mutations in which cause gaucher's disease while imiglucerase is a medication used in the treatment of gaucher's disease, a recombinant dna-produced analogue of human β-glucocerebrosidase.

In biochemistry|lang=en terms the difference between glucocerebroside and glucocerebrosidase

is that glucocerebroside is (biochemistry) any cerebroside containing glucose as the monosaccharide while glucocerebrosidase is (biochemistry) an enzyme that is needed to cleave, by hydrolysis, the beta-glucosidic linkage of glucocerebroside, an intermediate in glycolipid metabolism, and mutations in which cause gaucher's disease.

As nouns the difference between glucocerebroside and glucocerebrosidase

is that glucocerebroside is (biochemistry) any cerebroside containing glucose as the monosaccharide while glucocerebrosidase is (biochemistry) an enzyme that is needed to cleave, by hydrolysis, the beta-glucosidic linkage of glucocerebroside, an intermediate in glycolipid metabolism, and mutations in which cause gaucher's disease.